161 related articles for article (PubMed ID: 33917445)
1. Preparation of Co-Processed Excipients for Controlled-Release of Drugs Assembled with Solid Lipid Nanoparticles and Direct Compression Materials.
Serrano-Mora LE; Zambrano-Zaragoza ML; Mendoza-Muñoz N; Leyva-Gómez G; Urbán-Morlán Z; Quintanar-Guerrero D
Molecules; 2021 Apr; 26(7):. PubMed ID: 33917445
[TBL] [Abstract][Full Text] [Related]
2. Carnauba wax as a promising excipient in melt granulation targeting the preparation of mini-tablets for sustained release of highly soluble drugs.
Nart V; Beringhs AO; França MT; de Espíndola B; Pezzini BR; Stulzer HK
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):250-257. PubMed ID: 27770888
[TBL] [Abstract][Full Text] [Related]
3. Development of a solid supersaturated self-nanoemulsifying preconcentrate (S-superSNEP) of fenofibrate using dimethylacetamide and a novel co-processed excipient.
Patki M; Patel K
Drug Dev Ind Pharm; 2019 Mar; 45(3):405-414. PubMed ID: 30444435
[TBL] [Abstract][Full Text] [Related]
4. Understanding the Performance of a Novel Direct Compression Excipient Comprising Roller Compacted Chitin.
Abu Fara D; Al-Hmoud L; Rashid I; Chowdhry BZ; Badwan A
Mar Drugs; 2020 Feb; 18(2):. PubMed ID: 32079246
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a novel hydroxypropyl methylcellulose (HPMC) direct compression grade excipient for pharmaceutical tablets.
Allenspach C; Timmins P; Sharif S; Minko T
Int J Pharm; 2020 Jun; 583():119343. PubMed ID: 32305364
[TBL] [Abstract][Full Text] [Related]
6. New classification of directly compressible (DC) excipients in function of the SeDeM Diagarm Expert System.
Suñé-Negre JM; Roig M; Fuster R; Hernández C; Ruhí R; García-Montoya E; Pérez-Lozano P; Miñarro M; Ticó JR
Int J Pharm; 2014 Aug; 470(1-2):15-27. PubMed ID: 24792976
[TBL] [Abstract][Full Text] [Related]
7. Downstream processing of a ternary amorphous solid dispersion: The impacts of spray drying and hot melt extrusion on powder flow, compression and dissolution.
Davis MT; Potter CB; Walker GM
Int J Pharm; 2018 Jun; 544(1):242-253. PubMed ID: 29689366
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system.
Kalam MA; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K
J Drug Target; 2010 Apr; 18(3):191-204. PubMed ID: 19839712
[TBL] [Abstract][Full Text] [Related]
9. Development and Characterization of Multifunctional Directly Compressible Co-processed Excipient by Spray Drying Method.
Chauhan SI; Nathwani SV; Soniwala MM; Chavda JR
AAPS PharmSciTech; 2017 May; 18(4):1293-1301. PubMed ID: 27480443
[TBL] [Abstract][Full Text] [Related]
10. Novel approach for overcoming the stability challenges of lipid-based excipients. Part 3: Application of polyglycerol esters of fatty acids for the next generation of solid lipid nanoparticles.
Corzo C; Meindl C; Lochmann D; Reyer S; Salar-Behzadi S
Eur J Pharm Biopharm; 2020 Jul; 152():44-55. PubMed ID: 32387704
[TBL] [Abstract][Full Text] [Related]
11. Design of prolonged release tablets using new solid acrylic excipients for direct compression.
Villanova JC; Ayres E; Oréfice RL
Eur J Pharm Biopharm; 2011 Nov; 79(3):664-73. PubMed ID: 21827852
[TBL] [Abstract][Full Text] [Related]
12. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
[TBL] [Abstract][Full Text] [Related]
13. Co-proccessed excipients with enhanced direct compression functionality for improved tableting performance.
Rojas J; Buckner I; Kumar V
Drug Dev Ind Pharm; 2012 Oct; 38(10):1159-70. PubMed ID: 22966909
[TBL] [Abstract][Full Text] [Related]
14. Denatured Whey Protein Powder as a New Matrix Excipient: Design and Evaluation of Mucoadhesive Tablets for Sustained Drug Release Applications.
Hsein H; Garrait G; Tamani F; Beyssac E; Hoffart V
Pharm Res; 2017 Feb; 34(2):365-377. PubMed ID: 28004316
[TBL] [Abstract][Full Text] [Related]
15. Performance Evaluation of a Novel Biosourced Co-Processed Excipient in Direct Compression and Drug Release.
Benabbas R; Sanchez-Ballester NM; Aubert A; Sharkawi T; Bataille B; Soulairol I
Polymers (Basel); 2021 Mar; 13(6):. PubMed ID: 33807048
[TBL] [Abstract][Full Text] [Related]
16. Investigation of excipient type and level on drug release from controlled release tablets containing HPMC.
Williams RO; Reynolds TD; Cabelka TD; Sykora MA; Mahaguna V
Pharm Dev Technol; 2002 May; 7(2):181-93. PubMed ID: 12066573
[TBL] [Abstract][Full Text] [Related]
17. Towards a rational basis for selection of excipients: Excipient Efficiency for controlled release.
Casas M; Aguilar-de-Leyva Á; Caraballo I
Int J Pharm; 2015 Oct; 494(1):288-95. PubMed ID: 26253376
[TBL] [Abstract][Full Text] [Related]
18. Stability of lipid excipients in solid lipid nanoparticles.
Radomska-Soukharev A
Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical design of a new lactose-free coprocessed excipient: application of hydrochlorothiazide as a low solubility drug model.
Viscasillas Clerch A; Fernandez Campos F; Del Pozo A; Calpena Campmany AC
Drug Dev Ind Pharm; 2013 Jul; 39(7):961-9. PubMed ID: 22607083
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Eudragit RS-PO and Ethocel 100 matrices for the controlled release of lobenzarit disodium.
Boza A; Caraballo I; Alvarez-Fuentes J; Rabasco AM
Drug Dev Ind Pharm; 1999 Feb; 25(2):229-33. PubMed ID: 10065357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
